Paclitaxel plus cisplatin in cancer of unknown primary site (CUP).

被引:0
|
作者
Park, YH [1 ]
Ryoo, BY [1 ]
Choi, SJ [1 ]
Kim, HT [1 ]
机构
[1] Korea Canc Ctr Hosp, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2123
引用
收藏
页码:157S / 157S
页数:1
相关论文
共 50 条
  • [41] Prognostic Factors in Patients With Cancer of Unknown Primary (CUP)
    Petrakis, D.
    Voulgaris, E.
    Pentheroudakis, G.
    Pavlidis, N.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S673 - S673
  • [42] Update on the diagnosis of cancer of unknown primary (CUP) origin
    Aurelio Ariza
    Carmen Balañá
    Ángel Concha
    Ricardo Hitt
    Blanca Homet
    Alfredo Matilla
    Emilio Alba
    [J]. Clinical and Translational Oncology, 2011, 13 : 434 - 441
  • [43] Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP)
    Schaffer, Andrea L.
    Pearson, Sallie-Anne
    Perez-Concha, Oscar
    Dobbins, Timothy
    Ward, Robyn L.
    van Leeuwen, Marina T.
    Rhee, Joel J.
    Laaksonen, Maarit A.
    Craigen, Glynis
    Vajdic, Claire M.
    [J]. PLOS ONE, 2020, 15 (03):
  • [44] The evolving role of paclitaxel for patients with carcinoma of unknown primary site
    Greco, FA
    Hainsworth, JD
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (01) : 129 - 133
  • [45] Demographic, social and lifestyle risk factors for cancer registry-notified cancer of unknown primary site (CUP)
    Vajdic, C. M.
    Perez-Concha, O.
    Dobbins, T.
    Ward, R. L.
    Schaffer, A. L.
    van Leeuwen, M. T.
    Rhee, J. J.
    Laaksonen, M. A.
    Craigen, G.
    Pearson, S. A.
    [J]. CANCER EPIDEMIOLOGY, 2019, 60 : 156 - 161
  • [46] Paclitaxel/Carboplatin plus Bevacizumab/Erlotinib in the First-Line Treatment of Patients with Carcinoma of Unknown Primary Site
    Hainsworth, John D.
    Spigel, David R.
    Thompson, Dana S.
    Murphy, Patrick B.
    Lane, Cassie M.
    Waterhouse, David M.
    Naot, Yuval
    Greco, F. Anthony
    [J]. ONCOLOGIST, 2009, 14 (12): : 1189 - 1197
  • [47] Cancer of unknown primary (CUP) – lokal begrenzt, oligometastatisch und im Kopf-Hals-BereichCancer of unknown primary (CUP)—single-site, oligometastatic, and in the head and neck region
    Maria Pouyiourou
    Sebastian Regnery
    Tilmann Bochtler
    Klaus Herfarth
    Alwin Krämer
    [J]. Die Radiologie, 2023, 63 (5) : 358 - 365
  • [48] Neurotoxicity and ototoxicity of cisplatin plus paclitaxel in comparison to cisplatin plus cyclophosphamide in patients with epithelial ovarian cancer
    Cavaletti, G
    Bogliun, G
    Crespi, V
    Marzorati, L
    Zincone, A
    Marzola, M
    Rota, S
    Galli, A
    Tredici, P
    Tredici, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) : 199 - 206
  • [49] Cancer from an unknown primary site
    Dowell, JE
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 326 (01): : 35 - 46
  • [50] METASTATIC CANCER OF UNKNOWN PRIMARY SITE
    HOBBS, J
    RODRIGUEZ, AR
    [J]. AMERICAN FAMILY PHYSICIAN, 1980, 22 (03) : 164 - 168